Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/fda-approves-direct-biologics-to-proceed-with-a-landmark-phase-3-acute-respiratory-distress-syndrome-ards-trial-301530556.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-16-2022-1647498663.pdf
https://www.prnewswire.com/news-releases/direct-biologics-announces-fda-approval-for-proceeding-with-second-exoflo-ind-for-post-acute-covid-19-syndrome-and-chronic-post-covid-19-syndrome-858844123.html
https://www.prnewswire.com/news-releases/direct-biologics-granted-fda-approval-of-third-ind-application-for-the-use-of-exoflo-in-mild-to-moderate-covid-19-infusion-therapy-301322443.html